DOI QR코드

DOI QR Code

Establishment of a Stable Cell Line Expressing Green Fluorescence Protein-fused Hypoxia Inducible Factor-1α for Assessment of Carcinogenicity of Chemical Toxicants

  • 발행 : 2009.12.01

초록

Hypoxia inducible factor $1\alpha$ (HIF-$1\alpha$) is a potential marker of carcicnogenesis since it is overexpresssed in many human cancers such as brain, breast, and uterus, and its role has implicated in tumor cell growth and metastasis. In this study, we established a stable cell line that express green fluorescence protein (GFP)-fused hypoxia inducible factor $1\alpha$ (HIF-$1\alpha$) and evaluated the potential use of this cell line for assessment of carcinogenicity of chemical toxicants. Western blot analysis as well as fluorescence measurements showed that protein-level of GFP-HIF-$1\alpha$ was significantly enhanced in a dose-dependent manner upon treatment of hypoxia mimicking agents such as dexferrioxamine and $CoCl_2$. Well-Known tumor promoters such as mitomycin and methyl methanesulfonate. significantly induced the fluorescence intensity of GFP-HIF-$1\alpha$, whereas the known negative controls such as o-anthranilic acid and benzethonium chloride, did not. These results indicate that HIF-$1\alpha$ could be a biological parameter for detection of tumor initiators/promoters and suggest that the GFP-HIF-$1\alpha$ cell line is a useful system for screening of carcinogenic toxicants.

키워드

참고문헌

  1. Becerril, C., Ferrero, M., Sanz, F. and Castano, A. (1999). Detection of mitomycin C-induced genetic damage in fish celis by use of RAPD. Mutagenesis, 14, 449-456 https://doi.org/10.1093/mutage/14.5.449
  2. Berwald, Y. and Sachs, L. (1963). In vitro celi transformation with chemical carcinogens. Nature, 200, 1182-1184 https://doi.org/10.1038/2001182a0
  3. Biner, P., Schindl, M., Obermair, A., Breitenecker, G and Oberhuber, G (2001). Expression of hypoxia-inducible factor 1 alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin. Cancer Res., 7, 1661-1668
  4. Breheny, D., Zhang, J. and Massey, ED. (2005). Application of a two-stage Syrian hamster embryo celi transformation assay to cigarette smoke particulate matter. Mutat. Res., 572, 45-57 https://doi.org/10.1016/j.mrfmmm.2004.12.004
  5. Burri, P, Djonov, V, Aebersold, D.M., Lindel, K., Studer, U., Altermatt, H.J., Mazzucchelli, L., Greiner, RH. and Gruber, G (2003). Significant correlation of hypoxia-inducible factor-1 alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Int. J. Radiat. Oncol.Biol. Phys., 56, 494-501 https://doi.org/10.1016/S0360-3016(02)04579-0
  6. Chilakapati, J., Shankar, K., Korrapati, M.C., Hill, R.A. and Mehendale, H.M. (2005). Saturation toxicokinetics of thioacetamide: role in initiation of liver injury. Drug Metabo. Dispos., 33, 1877-1885
  7. Custer, L., Gibson, D.P., Aardema, M.J. and LeBoeuf, R.A. (2000). A refined protocol for conducting the low pH 6.7 Syrian hamster embryo (SHE) cell transformation assay. Mutat. Res., 455, 129-139 https://doi.org/10.1016/S0027-5107(00)00098-1
  8. Fang, M.l., Kim, DY, Lee, HW and Cho, M.H. (2001). Improvement of in vitro two-stage transformation assay and determination of the promotional effect of cadmium. Toxicol. In Vitro, 15, 225-231 https://doi.org/10.1016/S0887-2333(01)00012-1
  9. Grover, PL., Sins, P, Huberman, E., Marquardt, H., Kuroki, T. and Heidelberger, C. (1971). In vitro transformation of rodent cells by k-region derivatives of polycyclic hydrocarbons. Proc. Nat. Acad. Sci. USA, 68, 1098-1101 https://doi.org/10.1073/pnas.68.6.1098
  10. Haseman, J.K., Huff, J.E., Zeiger, E. and McConnell, E.E. (1987). Comparative results of 327 chemical carcinogenicity studies. Environ. Health Perspect., 74, 229-235 https://doi.org/10.2307/3430453
  11. Hong, I., Seo, HW, Lee, M.H., Kim, JW, Chung, J.H., Lee, B.H. and Lee, M.O. (2007). Establishment of reporter cell lines that monitor activities of hypoxia inducible factor1, P53 and Nur77 for assessment of carcinogenicity. J. Toxicol. PUb. Health, 23, 231-238
  12. Huang, L.E., Gu, J., Sxhau, M. amd Bunn, H.F. (1998). Regulation of hypoxia-inducible factor 1 alpha is mediated by an 02-dependent degradation domain via the ubiquitinproteasome pathway. Proc. Natl. Acad. Sci. U.S.A., 95, 7987-7992 https://doi.org/10.1073/pnas.95.14.7987
  13. Humble, N.M., Trempus, C.S., Spalding, J.W, Cannon, R.E. and Tennant, RW (2005). Biological, cellular, and molecular characteristics of an inducible transgenic skin tumor model: a review. Oncogene, 24, 8217-8228 https://doi.org/10.1038/sj.onc.1209000
  14. Labay, K., Ould-Elhkim, M., Kles, V, Guffroy, M., Poul, J.M. and Sanders, P (2001). Effects of griseofulvin in mediumterm liver carcinogenesis assay and peripheral blood micronucleus test in rat. Teratog. Carcinog. Mutagen., 21, 441-451 https://doi.org/10.1002/tcm.1031
  15. Lee, MY, Kim, M.A., Kim, H.J., Bae, YS., Park, J.I., Kwak, JY, Chung, J.H. and Yun, J. (2007). Alkylating agent methyl methanesulfonate (MMS) induces a wave of global protein hyperacetylation: Implications in cancer cell death. Biochem. Biophys. Res. Commum., 360, 483-489 https://doi.org/10.1016/j.bbrc.2007.06.084
  16. Lee, J.W, Bas, S.H., Jeong, J.W, Kim, S.H. and Kim, K.W. (2004). Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp. Mol. Med., 36, 1-12 https://doi.org/10.1038/emm.2004.1
  17. Machon, PC., Hirota, K. and Semenza, GL. (2001). FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev., 15, 2675-2686 https://doi.org/10.1101/gad.924501
  18. Mangipudy, R.S., Rao, P.S. And Mehendale, H.M. (1996). Effect of an antimitotic agent colchicines on thioacetamide hepatotoxicity. Environ. Health Perspect., 104, 744-749 https://doi.org/10.2307/3433220
  19. Schindl, M., Schoppmann, S.F., Samonigg, H., Hausmananinger, H., Kwasny, W, Gnant, M., Jakesz, R., Kubista, E., Birner, P., Pberhuber, G, Austrian Breast and Colorectal Cancer Study Group. (2002). Overexpression of hypoxia-inducible factor 1 alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin. Cancer Res., 8, 1831-1837
  20. Semenza, GL. (2003). Targeting HIF-1 for cancer therapy. Cancer, 3, 721-732
  21. Spalding, J.W, French, J.E., Tice, R.R Furedi-Machacek, M., Haseman, JK and Tennant, R.W (1999). Development of a transfenic mouse model for carcinogenesis bioassays: Evaluation of chemically induced skin tumors in Tg.AC mice. Toxicol. Sci., 49, 241-254 https://doi.org/10.1093/toxsci/49.2.241
  22. Swinson, D.E., Jones, J.L., Cox, G, Richardson, D., Harris, A.L. and O'Byrne, K.J. (2004). Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int. J. Cancer., 111, 43-50 https://doi.org/10.1002/ijc.20052
  23. Tennant, RW, Margolin, B.H., Shelby, M.D., Zeiger E., Haseman, J.K. Spalding, J., Caspary, W, Resnck, M., Stasiewicz, S., Anderson, E. and Minor, R. (1987). Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science, 236, 933-941 https://doi.org/10.1126/science.3554512
  24. Tennant, R.W (1988). Relationships between in vitro genetic toxicity and carcinogenisity studies in animals. Ann. N. Y. Acad. Sci., 534, 127-132 https://doi.org/10.1111/j.1749-6632.1988.tb30104.x
  25. Tomasz, M., Mercado, C.M., Olson, J. and Chatterjie, N. (1974). Mode of interaction of mitomycin C with deoxyribonucleic acid and other polynucleotides in vitro. Biochemistry, 13,4878-4887 https://doi.org/10.1021/bi00721a002
  26. Trosko, J.E. (2001). Commentary: Is the concept of 'tumor promotion' a useful paradigm? Mol. Carcinog., 3, 131-137
  27. Tsuchiya, T. and Umeda, M. (1997). Relationship between exposure to TPA and appearance of transformed cells in MNNG-initiated transformation of BALB/c3T3 cells. Int. J. Cancer, 73, 271-276 https://doi.org/10.1002/(SICI)1097-0215(19971009)73:2<271::AID-IJC18>3.0.CO;2-I
  28. Vesselinovitch, S.D. and Mihailovich, N.T. (1968). The inhibitory effect of greseofulvin on the 'promotion' of skin carcinogenesis. Cancer Res., 28, 2463-2465
  29. Wyatt, M.D. and Pittman, D.L. (2006). Methylating agents and DNA repair responses: Methylated bases and sources of strand breaks. Chem. Res. Toxicol., 19, 1580-1594 https://doi.org/10.1021/tx060164e
  30. Yoo, YG, Yeo, M.G, Kim, DK, Park, H. and Lee, M.O. (2004). Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1 alpha. J. BioI. Chem., 279, 53365-53373 https://doi.org/10.1074/jbc.M408554200
  31. Zagzag. D., Zhong, H., Scalzitti, J.M., Laughner, E., Simons, J.W and Semenza, G L. (2000). Expression of hypoxiainducible factor 1a in brain tumors. Cancer, 88, 2606-2618 https://doi.org/10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W
  32. Zhong., H., De Marzo, AM., Laughner, E., Lim, M., Hilton, D.A., Zag zag D., Buechler, P, Isaacs, WB., Semenza, GL. and Simons, J.W (1999). Overexpression of hypoxiainducible factor 1 a in commom human cancers and their metastases. Cancer Res., 835, 5830-5835